fluorodeoxyglucose f18 has been researched along with Spondylosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eicker, SO; Floeth, FW; Galldiks, N; Herdmann, J; Langen, KJ; Steiger, HJ; Stoffels, G | 1 |
| Sakushima, K; Sasaki, H; Shiga, T; Terae, S; Tsuji-Akimoto, S; Yabe, I; Yashima-Yamada, M | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Spondylosis
| Article | Year |
|---|---|
Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy.
Topics: Cervical Vertebrae; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Spinal Cord Diseases; Spondylosis | 2013 |
1 other study(ies) available for fluorodeoxyglucose f18 and Spondylosis
| Article | Year |
|---|---|
FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Spinal Cord Compression; Spinal Cord Diseases; Spondylosis | 2011 |